Standard Ethics
Action Date Description ISIN Industry Rating To Outlook Rating From Outlook
09 Mar 2018 Merck US58933Y1055 Biotech & Pharma E+ Stable
22 Feb 2018 Johnson & Johnson US4781601046 Biotech & Pharma E Stable
29 Nov 2017 Pfizer Inc. US7170811035 Biotech & Pharma Pending
22 Sep 2017 Lonza Group CH0013841017 Biotech & Pharma EE- Stable
17 May 2017 Grifols ES0171996087 Biotech & Pharma E Stable
08 Feb 2017 Recordati IT0003828271 Biotech & Pharma E+ Stable E+ Stable
27 Oct 2016 Bayer DE000BAY0017 Biotech & Pharma EE- Stable EE- Stable
17 Oct 2016 Shire JE00B2QKY057 Biotech & Pharma EE Stable
17 Oct 2016 AstraZeneca GB0009895292 Biotech & Pharma E+ Stable
17 Oct 2016 GlaxoSmithKline GB0009252882 Biotech & Pharma E Stable
29 Jun 2016 Galapagos BE0003818359 Biotech & Pharma E Stable
29 Feb 2016 Merck DE0006599905 Biotech & Pharma EE- Stable
29 Feb 2016 Bayer DE000BAY0017 Biotech & Pharma EE- Stable
01 Jul 2015 UCB BE0003739530 Biotech & Pharma E+ Stable
26 Jun 2015 Sanofi FR0000120578 Biotech & Pharma EE+ Stable
26 Jun 2015 Roche CH0012032048 Biotech & Pharma E Stable
26 Jun 2015 Novartis CH0012005267 Biotech & Pharma EE- Stable
26 Jun 2015 Actelion CH0010532478 Biotech & Pharma E+ Stable